BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

Incyte and Genesis have entered a strategic partnership for the research, discovery and development of new small-molecule ...

How can pharmaceutical firms shore up their sustainability credentials at a time when the entire research landscape is turning on its head? A recent webinar from supply chain leaders World Courier and ...

CSL Behring KK has gained approval from Japan's MHLW to manufacture and market subcutaneous injection 200mg Andembry pens.

AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...

X4 has entered an exclusive agreement with taiba rare for distributing and commercialising Xolremdi in select Middle Eastern ...

In this review, GlobalData considers the products both approved and priced in 2024 and the factors that influenced their ...

The World Health Organization (WHO) said it will conduct another mass vaccination round in the Gaza Strip to protect children ...

ImmunityBio has gained the FDA authorisation for an EAP to supply an alternative source of BCG for treating bladder cancer.

The FDA, NIH and CDC has cut 5,200 probationary staff in a job cull across the HHS over the Valentine's Day weekend.